The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -29.05%. However, over the past six months, we’ve seen a weaker performance of 35.36%. The price of VKTX fallen by 32.10% over the last 30 days. And in the last five days, it has surged by 27.21%.
The stock price for Viking Therapeutics Inc (VKTX) currently stands at $40.55. The stock experienced a substantial increase in the last session, hitting $125.0 after starting at $40.74. The stock’s lowest price was $33.0 before closing at $39.86.
Viking Therapeutics Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $81.73 on 10/28/24, while the lowest price for the same duration was marked at $18.92 on 04/09/25.
52-week price history of VKTX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Viking Therapeutics Inc’s current trading price is -50.38% away from its 52-week high, while its distance from the 52-week low is 114.34%. The stock’s price range during this period has varied between$18.92 and $81.73. The Viking Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.99 million for the day, a figure considerably lower than their average daily volume of 3.73 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Viking Therapeutics Inc (VKTX) has experienced a quarterly rise of 46.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.56B and boasts a workforce of 36 employees.
Viking Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 10 analysts are rating Viking Therapeutics Inc as a BUY, 6 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 28.34, with a change in price of +12.00. Similarly, Viking Therapeutics Inc recorded 3,919,139 in trading volume during the last 100 days, posting a change of +42.33%.
VKTX Stock Stochastic Average
As of today, Viking Therapeutics Inc’s raw stochastic average for the last 50 days stands at 92.72%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 87.54%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 87.94% and 89.00%, respectively.
